Skip to main content

Find Clinical Trials

Home
Conditions
Breast Neoplasms

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,836 public trials 1,783 recruiting studies

Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients

NCT01795586

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

NCT00490503

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer

NCT02549677

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Self-efficacy Coaching for Women With Breast Cancer

NCT03478384

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Tumorzentrum ZeTuP Rapperswil-Jona Rapperswil-Jona, Canton of St. Gallen, Switzerland

Prolindo, Onkologie & Hämatologie, Team am Lindenhofspital Bern, Switzerland

Spital Thurgau AG - Kantonsspital Frauenfeld Frauenfeld, Switzerland

Hirslanden Klinik St. Anna Lucerne, Switzerland

View Trial Details

Completed

Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03

NCT04109391

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Tanvex Investigational Site 1006E Grodno, Belarus

Tanvex Investigational Site 1003E Homyel, Belarus

Tanvex Investigational Site 1008E Lesnoy, Belarus

Tanvex Investigational Site 1002E Minsk, Belarus

View all 86 locations

View Trial Details

Completed

Elacestrant in Preoperative Setting, a Window of Opportunity Study

NCT04797728

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: ICO Badalona Badalona, Barcelona, Spain

Hospital General de Catalunya Sant Cugat del Vallès, Barcelona, Spain

Hospital Universitari Vall d'Hebron Barcelona, Spain

Hospital Clinic Barcelona Barcelona, Spain

View Trial Details

Completed

Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer

NCT04781712

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Samsung Medical Center Seoul, Gangnam-gu, South Korea

View Trial Details

Completed

Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer

NCT02489448

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations: Yale School of Medicine New Haven, Connecticut, United States

View Trial Details

Completed

A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

NCT00623831

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +50 more
Locations: Krankenhaus Nordwest Frankfurt, Germany

View Trial Details

Completed

A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer

NCT04676516

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: St. Joseph's Health Care London London, Ontario, Canada

View Trial Details